goldfinger
- 01 Oct 2009 08:52
- 2 of 4
Added a few more after this bullish broker note late yesterday....
INSTANT ANALYSIS: Misys IMS solid and reassuring
30 September, 2009 07:53:35 AM
That's the conclusion of Deutsche Bank,which repeats its buy advice and 250p a share price target after the latest trading update. Broker says revenues ahead of its forecasts, reassured by the big deal signed by the company's Allscripts division. Deutsche says: 'Pending further details in the conference call, we maintain estimates, recommendation and our price target, which is based on a 20% discount to the 13x mid-cycle EV/EBIT multiple, given the pressures on the Banking and TCM business in the early stages of macro recovery. Key risks: significant
market share loss in banking to close competitors, delays in BankFusion product roadmap, financing problems hinder business turnaround, healthcare business integration problems impact group.'
HARRYCAT
- 14 Jul 2010 10:26
- 3 of 4
StockMarketWire.com
"Software and services group Misys will release its results for the year to end-May on Tuesday, July 27.
Nasdaq-quoted Allscripts-Misys Healthcare Solutions, in which Misys owns a controlling stake, will announce its results on July 20 after the US stock markets close. "
dreamcatcher
- 04 Jun 2012 17:18
- 4 of 4
Misys +51pc
Banking software group, Misys, finished May with a flourish.
After a dramatic few months saw bidders enter the fray and then walk away, Misys finally agreed to a £1.29bn takeover by Vista Equity Partners in March.
With the deal complete, Misys left the London Stock Exchange on Friday, with its shares up 51pc from where they ended last year.
Private equity firm Vista said in March that it would pay 350p-a-share for Misys, seeing off a bid from rival CVC , which pulled out of the race to buy the FTSE 250 business. The deal came after talks for an all-share merger between Misys and Switzerland’s Temenos collapsed in March.